ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors

K Kaipio; S Potdar; J Hynninen; A Auranen; S Grénman; K Wennerberg; S Hautaniemi; O Carpén; P Chen; P Roering; K Huhtinen; P Mikkonen; P Östling; L Lehtinen; N Mansuri; T Korpela

doi:10.1002/path.5356

ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors

K Kaipio, S Potdar, J Hynninen, A Auranen, S Grénman, K Wennerberg, S Hautaniemi, O Carpén, P Chen, P Roering, K Huhtinen, P Mikkonen, P Östling, L Lehtinen, N Mansuri, T Korpela

Tutkimustuotos: Artikkeli › Scientific › vertaisarvioitu

9 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	159-169
Julkaisu	Journal of Pathology
Vuosikerta	250
Numero	2
DOI - pysyväislinkit	https://doi.org/10.1002/path.5356
Tila	Julkaistu - 2019
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Tutkimusalat

drug sensitivity
ovarian cancer
patient-derived cell line
stem-like cell
survival

Julkaisufoorumi-taso

Jufo-taso 2

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

Pääsy asiakirjaan

10.1002/path.5356

https://pubmed.ncbi.nlm.nih.gov/31595974

Siteeraa tätä

Kaipio, K., Potdar, S., Hynninen, J., Auranen, A., Grénman, S., Wennerberg, K., Hautaniemi, S., Carpén, O., Chen, P., Roering, P., Huhtinen, K., Mikkonen, P., Östling, P., Lehtinen, L., Mansuri, N., & Korpela, T. (2019). ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors. Journal of Pathology, 250(2), 159-169. https://doi.org/10.1002/path.5356

@article{c942b3e19d0e429da939c07d31e26663,

title = "ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors",

keywords = "drug sensitivity, ovarian cancer, patient-derived cell line, stem-like cell, survival, drug sensitivity, ovarian cancer, patient-derived cell line, stem-like cell, survival",

author = "K Kaipio and S Potdar and J Hynninen and A Auranen and S Gr{\'e}nman and K Wennerberg and S Hautaniemi and O Carp{\'e}n and P Chen and P Roering and K Huhtinen and P Mikkonen and P {\"O}stling and L Lehtinen and N Mansuri and T Korpela",

year = "2019",

doi = "10.1002/path.5356",

language = "English",

volume = "250",

pages = "159--169",

journal = "Journal of Pathology",

issn = "0022-3417",

publisher = "Wiley",

number = "2",

}

Kaipio, K, Potdar, S, Hynninen, J, Auranen, A, Grénman, S, Wennerberg, K, Hautaniemi, S, Carpén, O, Chen, P, Roering, P, Huhtinen, K, Mikkonen, P, Östling, P, Lehtinen, L, Mansuri, N & Korpela, T 2019, 'ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors', Journal of Pathology, Vuosikerta 250, Nro 2, Sivut 159-169. https://doi.org/10.1002/path.5356

TY - JOUR

T1 - ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors

AU - Kaipio, K

AU - Potdar, S

AU - Hynninen, J

AU - Auranen, A

AU - Grénman, S

AU - Wennerberg, K

AU - Hautaniemi, S

AU - Carpén, O

AU - Chen, P

AU - Roering, P

AU - Huhtinen, K

AU - Mikkonen, P

AU - Östling, P

AU - Lehtinen, L

AU - Mansuri, N

AU - Korpela, T

PY - 2019

Y1 - 2019

KW - drug sensitivity

KW - ovarian cancer

KW - patient-derived cell line

KW - stem-like cell

KW - survival

KW - drug sensitivity

KW - ovarian cancer

KW - patient-derived cell line

KW - stem-like cell

KW - survival

U2 - 10.1002/path.5356

DO - 10.1002/path.5356

M3 - Article

VL - 250

SP - 159

EP - 169

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 2

ER -